X-Square Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $970K | Sell |
57,864
-1,428
| -2% | -$23.9K | 0.35% | 82 |
|
|
2025
Q1 | $911K | Sell |
59,292
-1,890
| -3% | -$29K | 0.39% | 73 |
|
|
2024
Q4 | $1.35M | Sell |
61,182
-158,981
| -72% | -$3.5M | 0.55% | 56 |
|
|
2024
Q3 | $3.97M | Buy |
220,163
+6,500
| +3% | +$117K | 1.74% | 12 |
|
|
2024
Q2 | $3.47M | Buy |
213,663
+536
| +0.3% | +$8.71K | 1.61% | 14 |
|
|
2024
Q1 | $3.01M | Buy |
213,127
+15,649
| +8% | +$221K | 1.42% | 19 |
|
|
2023
Q4 | $2.06M | Sell |
197,478
-5,052
| -2% | -$52.8K | 1.14% | 26 |
|
|
2023
Q3 | $1.53M | Hold |
202,530
| – | – | 1.02% | 36 |
|
|
2023
Q2 | $1.53M | Sell |
202,530
-37,110
| -15% | -$279K | 1.02% | 36 |
|
|
2023
Q1 | $2.12M | Sell |
239,640
-13,000
| -5% | -$115K | 1.25% | 21 |
|
|
2022
Q4 | $2.3M | Sell |
252,640
-1,500
| -0.6% | -$13.7K | 1.31% | 21 |
|
|
2022
Q3 | $2.05M | Buy |
254,140
+1,624
| +0.6% | +$13.1K | 1.3% | 21 |
|
|
2022
Q2 | $1.9M | Buy |
252,516
+49,165
| +24% | +$370K | 1.14% | 26 |
|
|
2022
Q1 | $1.91M | Buy |
203,351
+1,987
| +1% | +$18.7K | 0.99% | 35 |
|
|
2021
Q4 | $1.61M | Buy |
201,364
+1,006
| +0.5% | +$8.06K | 0.81% | 44 |
|
|
2021
Q3 | $1.95M | Sell |
200,358
-5,396
| -3% | -$52.5K | 1.01% | 35 |
|
|
2021
Q2 | $2.03M | Sell |
205,754
-22,217
| -10% | -$219K | 0.96% | 36 |
|
|
2021
Q1 | $2.63M | Buy |
227,971
+10,382
| +5% | +$120K | 1.22% | 17 |
|
|
2020
Q4 | $2.1M | Buy |
217,589
+12,918
| +6% | +$125K | 1.13% | 22 |
|
|
2020
Q3 | $1.84M | Sell |
204,671
-5,394
| -3% | -$48.6K | 1.33% | 18 |
|
|
2020
Q2 | $2.59M | Buy |
210,065
+2,269
| +1% | +$28K | 1.84% | 11 |
|
|
2020
Q1 | $1.87M | Buy |
+207,796
| New | +$1.87M | 1.86% | 15 |
|